Literature DB >> 12762096

Pharmacologic agents associated with a preventive effect on Alzheimer's disease: a review of the epidemiologic evidence.

B A in 't Veld1, L J Launer, M M B Breteler, A Hofman, B H Ch Stricker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12762096     DOI： 10.1093/epirev/mxf001

Source DB:  PubMed          Journal:  Epidemiol Rev        ISSN： 0193-936X            Impact factor:   6.222


× No keyword cloud information.
  13 in total

1.  Association study of polymorphisms in the cyclooxygenase-2 gene and Alzheimer's disease risk in Chinese.

Authors:  Wenlu Tang; Meixia He; Bo Yang; Kankan Wei; Ming Yin; Lirong Zhang
Journal:  Neurol Sci       Date:  2012-05-24       Impact factor: 3.307

Review 2.  Epidemiology of schizophrenia: review of findings and myths.

Authors:  Erick L Messias; Chuan-Yu Chen; William W Eaton
Journal:  Psychiatr Clin North Am       Date:  2007-09

Review 3.  Mild cognitive impairment prevention: diet, sports and treatment approaches.

Authors:  V V Zakharov; N N Yakhno
Journal:  J Nutr Health Aging       Date:  2008-01       Impact factor: 4.075

4.  Dementia and Alzheimer's disease: a new direction.The 2010 Jay L. Foster Memorial Lecture.

Authors:  Lewis H Kuller; Oscar L Lopez
Journal:  Alzheimers Dement       Date:  2011-09       Impact factor: 21.566

Review 5.  COX-2 inhibitors as adjunctive therapy in schizophrenia: rationale for use and evidence to date.

Authors:  Michael Riedel; Martin Strassnig; Markus J Schwarz; Norbert Müller
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

6.  Systemic LPS administration induces brain inflammation but not dopaminergic neuronal death in the substantia nigra.

Authors:  Hey-Kyeong Jeong; Ilo Jou; Eun-hye Joe
Journal:  Exp Mol Med       Date:  2010-12-31       Impact factor: 8.718

Review 7.  Acetylated tau in Alzheimer's disease: An instigator of synaptic dysfunction underlying memory loss: Increased levels of acetylated tau blocks the postsynaptic signaling required for plasticity and promotes memory deficits associated with tauopathy.

Authors:  Tara E Tracy; Li Gan
Journal:  Bioessays       Date:  2017-01-13       Impact factor: 4.345

8.  Dexamethasone diminishes the pro-inflammatory and cytotoxic effects of amyloid beta-protein in cerebrovascular smooth muscle cells.

Authors:  Mary Lou Previti; Weibing Zhang; William E Van Nostrand
Journal:  J Neuroinflammation       Date:  2006-08-03       Impact factor: 8.322

9.  Thrombin, a mediator of cerebrovascular inflammation in AD and hypoxia.

Authors:  Debjani Tripathy; Alma Sanchez; Xiangling Yin; Jinhua Luo; Joseph Martinez; Paula Grammas
Journal:  Front Aging Neurosci       Date:  2013-05-09       Impact factor: 5.750

Review 10.  A review: inflammatory process in Alzheimer's disease, role of cytokines.

Authors:  Jose Miguel Rubio-Perez; Juana Maria Morillas-Ruiz
Journal:  ScientificWorldJournal       Date:  2012-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.